Aza-Darzens Asymmetric Synthesis
J . Org. Chem., Vol. 64, No. 20, 1999 7565
128.1, 127.9, 127.6, 125.0, 51.9, 42.1, 34.8, 21.5. Anal. Calcd
for C17H17NO3S: C, 64.74; H, 5.43. Found: C, 64.72; H, 5.50.
t r a n s-(Ss,2S ,3R )-(+)-N -(p -Tolu e n e su lfin yl)-2-ca r b o-
NNaO3S (m+Na) 406.0701, found 406.0699. Anal. Calcd for
C
18H16NF3SO3: C, 56.40; H, 4.18; N, 3.66. Found: C, 56.00;
H, 4.27; N, 3.21.
m eth oxy-3-p h en yla zir id in e (4a ): oil; [R]20 38.3 (c 0.2,
cis-(Ss,2S,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-(3-p yr id yl)a zir id in e (3f). The typical one-step procedure
was followed; 82% de; eluant, Et2O:EtOAc (1:1); yield 63%; mp
74-76 °C; [R]20D 51.9 (c 1.1, CHCl3); IR (KBr) cm-1 1718, 1576,
D
CHCl3); IR (neat) cm-1 2952, 1735, 1438, 1206, 1109; 1H NMR
(CDCl3) δ 7.70 (d, 2H, J ) 8.0 Hz), 7.30-7.24 (m, 5H), 7.17-
7.13 (m, 2H), 3.90 (d, 1H, J ) 4.0 Hz), 3.84 (s, 3H), 3.31 (d,
1H, J ) 3.5 Hz), 2.39 (s, 3H); 13C NMR (CDCl3) δ 167.7, 142.7,
141.9, 134.0, 129.7, 128.4, 126.9, 125.3, 52.9, 45.1, 44.0, 21.5.
Anal. Calcd for C17H17NO3S: C, 64.74; H, 5.43; N, 4.44.
Found: C, 64.61; H, 5.50; N, 4.67.
1
1424, 1096; H NMR (CDCl3) δ 8.71 (d, 1H, J ) 1.5 Hz), 8.57
(dd, 1H, J ) 1.5 Hz, 5.0 Hz), 7.84 (dt, 1H, J ) 1.5 Hz, 8.0 Hz),
7.71 (d, 2H, J ) 8.5 Hz), 7.36 (d, 2H, J ) 8.5 Hz), 7.30-7.27
(m, 1H), 3.88 (d, 1H, J ) 7.0 Hz), 3.52 (d, 1H, J ) 7.0 Hz),
3.42 (s, 3H), 2.44 (s, 3H); 13C NMR (CDCl3) δ 166.5, 150.3,
150.2, 143.2, 141.1, 136.3, 130.5, 129.3, 125.8, 123.7, 52.9, 40.7,
35.1, 22.2. Anal. Calcd for C16H16N2O3S: C, 60.74; H, 5.10; N,
8.85. Found: C, 60.53; H, 5.13; N, 8.71.
ci s-(S R ,2R ,3R )-(-)-N -(p -T o lu e n e s u lfin y l)-2-c a r b o -
m eth oxy-3-p h en yla zir id in e (3a ). The typical two-step pro-
cedure was followed using (R)-(-)-2a ; 98% de; eluant, EtOAc/
hexanes (2:8); yield 70%; oil; [R]20 -50.8 (c 1.5, CHCl3); its
D
spectral properties were identical to (Ss,2S, 3S)-(+)-3a .
cis-(Ss,2S,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-(p-m eth oxyp h en yl)a zir id in e (3b). The typical two-step
procedure was followed; 98% de; eluant, EtOAc/n-pentane (3:
cis-(Ss,2S,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-[(2-p h en yl)-E-1-eth en yl]a zir id in e (3g). The typical two-
step procedure was followed; 98% de; eluant, EtOAc:n-pentane
(3:7); yield 0.43 g (50%); mp 107-109 °C; [R]20 109.0 (c 1.0,
D
7); yield 0.23 g (74%); oil; [R]20 26.4 (c 1.7, CHCl3); IR (neat)
CHCl3); IR (KBr) cm-1 1735, 1593, 1210, 1095, 1074; 1H NMR
(CDCl3) δ 7.64 (d, 2H, J ) 8.1 Hz), 7.42-7.25 (m, 7H), 6.85 (d,
1H, J ) 16.0 Hz), 6.23 (dd, 1H, J ) 8.3 Hz, 16.0 Hz), 3.61 (s,
3H), 3.50-3.39 (m, 2H), 2.42 (s, 3H); 13C NMR (CDCl3) δ 166.9,
142.0, 140.5, 136.4, 135.6, 129.5, 128.4, 128.1, 126.4, 124.6,
121.2, 52.3, 42.6, 32.7, 21.5. Anal. Calcd for C19H19NO3S: C,
66.83; H, 5.61. Found: C, 66.38; H, 5.65.
D
cm-1 3001, 1752, 1596, 1204, 1074; H NMR (CDCl3) δ 7.54
1
(d, 2H, J ) 8.2 Hz), 7.22 (d, 2H, J ) 8.8 Hz), 7.16 (d, 2H, J )
8.2 Hz), 6.69 (d, 2H, J ) 8.8 Hz), 3.66 (d, 1H, J ) 7.3 Hz),
3.62 (s, 3H), 3.28 (d, 1H, J ) 7.3 Hz), 3.23 (s, 3H), 2.25 (s,
3H); 13C NMR (CDCl3) δ 166.0, 159.4, 142.0, 140.6, 129.6,
128.9, 125.1, 124.4, 113.5, 55.2, 52.1, 42.0, 34.9, 21.6. Anal.
Calcd for C18H19NO4S: C, 62.59; H, 5.54. Found: C, 62.48; H,
5.28.
cis-(Ss,2S,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-isop r op yla zir id in e (3h ). The typical one-step procedure
was followed; 56% de; eluant, EtOAc/n-pentane (1:9); yield 0.55
cis-(Ss,2S,3S)-(-)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-(p-m eth ylth iop h en yl)a zir id in e (3c). The typical two-step
procedure was followed; 98% de; eluant, EtOAc/n-pentane (3:
7); yield 64%; mp 86-88 °C; [R]20D -2.3 (c 0.5, CHCl3); IR (KBr)
g (73%); mp 52-55 °C; [R]20 110.7 (c 1.3, CHCl3); IR (neat)
D
cm-1 2964, 1752, 1597, 1203, 1074; H NMR (CDCl3) δ 7.62
1
(d, 2H, J ) 8.1 Hz), 7.29 (d, 2H, J ) 8.1 Hz), 3.61 (s, 3H), 3.21
(d, 1H, J ) 7.3 Hz), 2.49 (dd, 1H, J ) 7.4 Hz, 9.8 Hz), 2.40 (s,
3H), 1.89-1.71 (m 1H), 1.17 (d, 3H, J ) 6.6 Hz), 0.93 (d, 3H,
J ) 6.6 Hz),. 13C NMR (CDCl3) δ 167.2, 141.5, 140.9, 129.2,
124.5 51.8, 47.4, 31.6, 26.7, 21.2, 20.4, 19.1. Anal. Calcd for
1
cm-1 1751, 1592, 1495, 1437, 1095; H NMR (CDCl3) δ 7.70
(d, 2H, J ) 8.1 Hz), 7.39 (d, 2H, J ) 8.2 Hz), 7.33 (d, 2H, J )
8.1 Hz), 7.20 (d, 2H, J ) 8.2 Hz), 3.82 (d, 1H, J ) 7.3 Hz),
3.47 (d, 1H, J ) 7.3 Hz), 3.41 (s, 3H), 2.47 (s, 3H), 2.42 (s,
3H); 13C NMR (CDCl3) δ 166.1, 142.3, 140.8, 138.9, 129.8,
129.3, 128.3, 126.1, 125.2, 52.1, 41.9, 34.9, 21.5, 15.6. Anal.
Calcd for C18H19NO3S2: C, 59.82; H, 5.30. Found: C, 60.12;
H, 5.52.
C
14H19NO3S: C, 59.76; H, 6.80. Found: C, 59.77; H, 6.95.
t r a n s-(Ss,2S ,3R )-(+)-N -(p -Tolu e n e su lfin yl)-2-ca r b o-
m et h oxy-3-isop r op yla zir id in e (4h ). The typical one-step
procedure was followed; yield 0.18 g (24%); oil; [R]20 30.7 (c
D
1
cis-(Ss,2S,3S)-(-)-N-(p -Tolu en esu lfin yl)-2-ca r b o-ter t-
bu toxy-3-(p-m eth ylth iop h en yl)a zir id in e (5c). The typical
two-step procedure was followed; 74% de; eluant, EtOAc/n-
pentane (2:8); yield 0.58 g (71%); oil; [R]20D -16.6 (c 1.2, CHCl3);
IR (KBr) cm-1 2978, 1744, 1368, 1153; 1H NMR (CDCl3) δ 7.43
(d, 2H, J ) 8.2 Hz), 7.41-7.20 (m, 6H), 3.79 (d, 1H, J ) 7.4
Hz), 3.36 (d, 1H, J ) 7.4 Hz), 2.47 (s, 3H), 2.43 (s, 3H), 1.10 (s,
9H); 13C NMR (CDCl3) δ 164.2, 141.4, 140.8, 138.1, 129.3,
129.1, 127.9, 125.5, 124.9, 81.4, 41.3, 35.4, 27.3, 21.2, 15.5.
Anal. Calcd for C21H25NO3S2: C, 65.50; H, 6.24. Found: C,
65.10; H, 6.46.
1.2, CHCl3); IR (neat) cm-1 2962, 1745, 1440, 1228, 1093; H
NMR (CDCl3) δ 7.59 (d, 2H, J ) 8.0 Hz), 7.27 (d, 2H, J ) 8.5
Hz), 3.63 (s, 3H), 3.15 (d, 1H, J ) 4.0 Hz), 2.77 (dd, 1H, J )
4.0 Hz, 9.5 Hz), 2.38 (s, 3H), 1.95-1.85 (m, 1H), 1.06 (d, 3H,
J ) 7.0 Hz), 0.98 (d, 3H, J ) 7.0 Hz); 13C NMR (CDCl3) δ 168.9,
142.7, 141.7, 129.5, 124.9, 52.4, 51.1, 34.1, 27.9, 22.1, 21.4, 21.3;
HRMS calcd for C14H20NSO3 (M + H) 282.1164, found 282.1166.
Anal. Calcd for C14H19NSO3: C, 59.79; H, 6.76; N, 4.98.
Found: C, 59.36; H, 6.51; N, 4.90.
P r ep a r a tion of tr a n s- a n d cis-N-(p-Tolu en esu lfin yl)-
2-m eth yl-2-ca r bom eth oxy-3-p h en yla zir id in e (7a a n d 8a ).
Typ ica l P r oced u r e. In a 250 mL, two-necked, round-bot-
tomed flask fitted with a magnetic stirring bar, a rubber
septum, and an argon-filled balloon was placed 11.1 mL (11.1
mmol, 1.0 M in THF) of LiHMDS in THF (60 mL). The solution
was cooled to -78 °C, and 1.24 mL (11.1 mmol) of methyl
R-bromopropionate was slowly added. After 35 min 1.00 g (4.11
mmol) of (S)-(+)-2a in THF (40 mL) precooled to -78 °C was
added to the enolate via a cotton-wrapped, double-ended needle
over a period of 30 min. The reaction mixture was stirred for
0.5 h, quenched with H2O (4 mL), and diluted with EtOAc (40
mL). The organic phase was separated, and the aqueous phase
was washed with EtOAc (2 × 20 mL). The combined organic
extracts were washed with brine (20 mL), dried (MgSO4), and
concentrated to give a crude 95:5 mixture of diastereomers.
Purification by flash chromatography (EtOAc:n-pentane, 1:4)
afforded 1.14 g (85%) of trans-(2R,3S)-7a and 0.04 g (2%) of
cis-(2S,3S)-8a .
cis-(Ss,2S,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-(4-m eth ylsu lfon ylp h en yl)a zir id in e (3d ). The typical one-
step procedure was followed; 41% de; eluant, EtOAc/hexanes
(presaturated with ammonia, 4:6); yield 0.34 (55%); mp 139-
140 °C; [R]20 14.0 (c 0.4, CHCl3); IR (KBr) cm-1 3006, 1746,
D
1
1315, 1206, 1146, 1092; H NMR (CDCl3) δ 7.86 (d, 2H, J )
8.4 Hz), 7.64 (d, 4H, J ) 8.4 Hz), 7.29 (d, 2H, J ) 8.1 Hz),
3.85 (d, 1H, J ) 7.5 Hz), 3.48 (d, 1H, J ) 7.5 Hz), 3.34 (s, 3H),
3.30 (s, 3H), 2.37 (s, 3H); 13C NMR (CDCl3) δ 165.6, 142.5,
140.3, 138.9, 129.9, 129.8, 129.0, 128.9, 127.3, 127.1, 125.1,
124.9, 52.2, 44.4, 41.4, 34.7, 21.5; HRMS calcd for C18H20NS2O5
(M + H) 394.0783, found 394.0774. Anal. Calcd for C18H19
-
NS2O5: C, 54.96; H, 4.83; N, 3.56. Found: C, 55.21; H, 4.87;
N, 3.39.
cis-(Ss,2S,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-car bom eth oxy-
3-(4-tr iflu or om eth ylp h en yl)a zir id in e (3e). The typical one-
step procedure was followed; 42% de; eluant, EtOAc/hexanes
(2:8); yield 0.35 g (61%); mp 89-90 °C; [R]20 42.1 (c 0.4,
tr a n s-(Ss,2R,3S)-(+)-N-(p-Tolu en esu lfin yl)-2-m eth yl-2-
D
CHCl3); IR (KBr) cm-1 2954, 1752, 1325, 1167, 1125; 1H NMR
(CDCl3) δ 7.72 (d, 2H, J ) 8.0 Hz), 7.61 (s, 4H), 7.34 (d, 2H, J
) 8.0 Hz), 3.90 (d, 1H, J ) 7.0 Hz), 3.53 (d, 1H, J ) 7.0 Hz),
3.40 (s, 3H), 2.43 (s, 3H); 13C NMR (CDCl3) δ 165.8, 142.5,
140.5, 136.7, 130.4 (q, J ) 129 Hz, CF3), 129.8, 128.4, 125.8,
125.1, 122.2, 52.1, 41.6, 34.7, 21.4; HRMS calcd for C18H16F3-
ca r bom eth oxy-3-p h en yla zir id in e (7a ): yield 85%; oil; [R]20
D
99.6 (c 0.22, CHCl3); IR (neat) cm-1 2950, 1732, 1284, 1154,
1
1102; H NMR (CDCl3) δ 7.75 (d, 2H, J ) 8.1 Hz), 7.31-7.16
(m, 7H), 4.23 (s, 1H), 3.83 (s, 3H), 2.38 (s, 3H), 1.19 (s, 3H);
13C NMR (CDCl3) δ 169.3, 142.1, 142.0, 133.1, 129.4, 128.0,
127.8, 127.3, 125.1, 52.8, 49.6 47.5, 21.3, 15.6; HRMS calcd